Is Claritev Corporation (CTEV) a Buy, Sell, or Hold?
Claritev Corporation
NYSE:CTEV
$28.36 USD
-$1.48 (-4.96%)
- Volume
- 218.35K
- Average Volume
- 144.85K
- Market Capitalization
- $483.48M
- P/E Ratio
- -1.64
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $74.07
- Year Low
- $11.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.28
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Travis S. Dalton |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | CTEV |
| CUSIP | 62548M209 |
| CIK | 0001793229 |
| Web | https://www.claritev.com |
| Phone | (212) 780-2000 |
| Currency | USD |
| Employees | 3000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -19.11 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.28 |
| Quick Ratio | 1.28 |
| Cash Ratio | 0.11 |
Sales & Book Value
| Annual Sales | $965.41M |
| Price / Sales | 0.49 |
| Cash Flow | -2.15 |
| Price / Cash Flow | -13.47 |
| Price / Book | -1.96 |
Price Target and Rating
| Average Stock Price Forecast | $34.00 |
| High Stock Price Forecast | $61.00 |
| Low Stock Price Forecast | $28.00 |
| Forecast Upside/Downside | -16.59% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 4 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-17.3 |
| Trailing P/E Ratio | -1.64 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-284.28M |
| Net Margin | -29.27% |
| Pretax Margin | -33.58% |
| Return on Equity | 205.84% |
| Return on Assets | -5.92% |
Financials Score
| AltmanZ Score | -0.40 |
| Piotroski Score | 5.00 |
| Working Capital | 52.7M |
| Total Assets | 4.84B |
| Ebit | 69.57M |
| Market Cap | 508.71M |
| Total Liabilities | 5.07B |
Poll Results
About Claritev Corporation (NYSE:CTEV) Stock
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and rem ... oving erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
2026-07-09 09:00:00
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (NYSE: CTEV), a technology, data, and insights company focused on making healthcare more affordable and transparent, today announced it has been recognized as a Leader in the Everest Group Pre-payment Integrity Solutions PEAK Matrix® Assessment 2026. The recognition and ascent into the Leader category reflects Claritev's longstanding history and continued investment in technology-enabled payment integrity that helps health plans identify potent.
2026-06-23 13:02:00
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “The Data Before the AI: Building the Foundation for Scalable Healthcare Intelligence” with Michael Kim.
2026-06-03 10:00:00
Claritev Cares, the charitable foundation established by Claritev (NYSE: CTEV), and the Elizabeth Dole Foundation today announced a new collaboration giving mi
2026-06-03 09:00:00
MCLEAN, Va. & WASHINGTON--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Cares, the charitable foundation established by Claritev (NYSE: CTEV), and the Elizabeth Dole Foundation today announced a new collaboration giving military and veteran caregivers and their families practical guides and resources to navigate their mental health insurance benefits. Developed with Claritev's healthcare subject matter expertise and hosted through the Elizabeth Dole Foundation's trusted caregiver platform, the new web-based guidan.
2026-06-02 17:53:00
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Claritev (CTEV) To Contact Him Directly To Discuss Their Options
2026-05-28 19:00:00
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE:CTEV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On May 14, 2026, The Capitol Forum reported that the U.S. Department of Justice's anti-trust division has launched a c.
2026-05-26 19:00:00
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE:CTEV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
2026-05-26 19:00:00
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
Frequently Asked Questions
-
What is the current Claritev Corporation (CTEV) stock price?
-
Claritev Corporation(NYSE:CTEV) stock price is $28.36 in the last trading session. During the trading session, CTEV stock reached the peak price of $74.07 while $11.5 was the lowest point it dropped to. The percentage change in CTEV stock occurred in the recent session was --4.96% while the dollar amount for the price change in CTEV stock was -$-1.48.
-
CTEV's industry and sector of operation?
-
The NYSE listed CTEV is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of CTEV?
-
Alwyn Van Heerdan | Vice President of Strategy & Corporate Development
Travis S. Dalton | Chief Executive Officer, President & Chairman
Tara A. O'Neil | Chief Legal Officer
Brock Albinson | Senior Vice President & Chief Accounting Officer
Douglas Garis | Executive Vice President & Chief Financial Officer -
How many employees does CTEV have?
-
Number of CTEV employees currently stands at 3000. CTEV operates from 115 Fifth Avenue, New York City, NY 10003, US.
-
Link for CTEV official website?
-
Official Website of CTEV is: https://www.claritev.com
-
How do I contact CTEV?
-
CTEV could be contacted at phone #(212) 780-2000 and can also be accessed through its website. CTEV operates from 115 Fifth Avenue, New York City, NY 10003, US.
-
How many shares of CTEV are traded daily?
-
The average number of CTEV shares traded daily for last 3 months was 144.85K.
-
What is the market cap of CTEV currently?
-
The market value of CTEV currently stands at $483.48M with its latest stock price at $28.36